Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice

Stem Cells and Development

Volumn 16, Issue 3, 2007, Pages 347-353

  Campbell, Timothy B ^a,b,c   Hangoc, Giao ^a,b,c   Liu, Ying ^a,b,c   Pollok, Karen ^a,b   Broxmeyer, Hal E ^a,b,c  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; PEPTIDASE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENGRAFTMENT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD26; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; FETAL BLOOD; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; OLIGOPEPTIDES; PHENOTYPE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 34347366261     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.9995     Document Type: Article

References (29)

1. Broxmeyer HE. (2006). Umbilical cord blood stem cells: collection, processing, and transplantation. In: Blood Banking and Transfusion Medicine: Basic Principles and Practice. CD Hillyer, LE Silberstein, PM Ness, KC Anderson and J Roback, eds. Churchill Livingston, an imprint of Elsevier, Inc., pp 823-832.
2. Lewis ID. (2002). Clinical and experimental uses of umbilical cord blood. Intern Med J 32:601-609.
3. Yao CL, YH Feng, XZ Lin, IM Chu, TB Hsieh and SM Hwang. (2006). Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. Stem Cells Dev 15:70-78.
4. Levac K, F Karanu and M Bhatia. (2005). Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo. Haematologica 90:166-172.
5. + cells. Transfusion 41:213-218.
6. Christopherson KW, 2nd, G Hangoc, CR Mantel and HE Broxmeyer. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000-1003.
7. Pro B and NH Dang. (2004). CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol 19:1345-1351.
8. Demuth HU, CH McIntosh and RA Pederson. (2005). Type 2 diabetes - therapy with dipeptidyl peptidase IV inhibitors. Biochim Biophys Acta 1751:33-44.
9. Fleischer B. (1994). CD26: a surface protease involved in T-cell activation. Immunol Today 15:180-184.
10. Christopherson KW, 2nd, S Cooper and HE Broxmeyer. (2003). Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101:4680-4686.
11. Peled A, I Petit, O Kollet, M Magid, T Ponomaryov, T Byk, A Nagler, H Ben-Hur, A Many, L Shultz, O Lider, R Alon, D Zipori and T Lapidot. (1999). Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-848.
12. Broxmeyer HE, S Cooper, L Kohli, G Hangoc, Y Lee, C Mantel, DW Clapp and CH Kim. (2003). Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 170:421-429.
13. Broxmeyer HE, L Kohli, CH Kim, Y Lee, C Mantel, S Cooper, G Hangoc, M Shaheen, X Li and DW Clapp. (2003). Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukocyte Biol 73:630-638.
14. Broxmeyer HE, CM Orschell, DW Clapp, G Hangoc, S Cooper, PA Plett, WC Liles, X Li, B Graham-Evans, TB Campbell, G Calandra, G Bridger, DC Dale and EF Srour. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201:1307-1318.
15. + progenitors to peripheral blood. J Exp Med 185:111-120.
16. Kim CH and HE Broxmeyer. (1998). In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91:100-110.
17. Wright DE, EP Bowman, AJ Wagers, EC Butcher and IL Weissman. (2002). Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 195:1145-1154.
18. Rosu-Myles M, L Gallacher, B Murdoch, DA Hess, M Keeney, D Kelvin, L Dale, SS Ferguson, D Wu, F Fellows and M Bhatia. (2000). The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci USA 97:14626-14631.
19. + progenitor cells. J Immunol 169:7000-7008.
20. Tian C, J Bagley, D Forman and J Iacomini. (2006). Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther 13:652-658.
21. Peranteau WH, M Endo, OO Adibe, A Merchant, PW Zoltick and AW Flake. (2006). CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 108:4268-4274.
22. -. Leukemia 17:960-964.
23. Bock TA, D Orlic, CE Dunbar, HE Broxmeyer and DM Bodine. (1995). Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 182:2037-2043.
24. Bhatia M, JC Wang, U Kapp, D Bonnet and JE Dick. (1997). Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320-5325.
25. Janeway C. Immunobiology: The Immune System in Health and Disease. (2005). Garland Science, New York.
26. + blood cells. Blood 87:4903-4909.
27. - cells in cord blood and bone marrow. Blood 86:3745-3753.
28. Broxmeyer HE, G Hangoc, S Cooper, T Campbell, S Ito and C Mantel. (2007). AMD3100 and CD26 modulate the mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Ann NY Acad Sci USA (in press).
29. Deacon CF and JJ Holst. (2006). Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. Int J Biochem Cell Biol 38:831-844.